Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of genomic oxidative-reductive balance as predictor of complex regional pain syndrome development: a novel theory.

Pain physician - 1 Jan 2000

Smith Howard S

Abstract excerpt

The aftermath of sequencing the human genome has birthed many efforts to utilize an individual's genetic information in order to tailor optimal treatment strategies - so-called personalized medicine. An individual's genetic information may eventually help diagnosis and treatment, as well selectin...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antioxidants
Share to Genetic Predisposition to Disease
Share to Genetic Variation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome, Human

Share to NF-E2-Related Factor 2

Share to Oxidation-Reduction

Share to Oxidative Stress

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 20119466

Genes

DRD2
GCH1
OPRM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-20119466-2026-09-04.1. Manifest publication-graph-cohort-2026-09-04.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of genomic oxidative-reductive balance as predictor of complex regional pain syndrome development: a novel theory.PMID 20119466Read ↗

Genetic modulation of the pharmacological treatment of pain.Semantic proximity Read ↗

Association between oxidative stress and chronic orofacial pain and potential druggable targets: Evidence from a Mendelian randomization study.Semantic proximity Read ↗

Pain and genetics.Semantic proximity Read ↗

[Genetics, pain and analgesia].Semantic proximity Read ↗

DNA based customized nutraceutical "gene therapy" utilizing a genoscore: a hypothesized paradigm shift of a novel approach to the diagnosis, stratification, prognosis and treatment of inflammatory processes in the human.Semantic proximity Read ↗

Personalized medicine--one size fits one: tailoring pain therapy to individuals' needs.Semantic proximity Read ↗

Fundamental Considerations for GeneticallyGuided Pain Management with Opioids Based on CYP2D6 and OPRM1 PolymorphismsSemantic proximity Read ↗

Pharmacogenomics of opioids and perioperative pain management.Semantic proximity Read ↗

Variations in critical morphine biosynthesis genes and their potential to influence human health.Semantic proximity Read ↗

Current evidence for a modulation of low back pain by human genetic variants.Semantic proximity Read ↗

Genetic factors in pain and its treatment.Semantic proximity Read ↗

A Review of the Role of Genetic Testing in Pain MedicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.